Zoratti found that the serine protease ST14 specifically cleaves the inactive pro-form of the hepatocyte growth factor (pro-HGF), promotes the release of HGF, binds c-Met, and then promotes the proliferation and invasion of inflammatory breast cancer cells [56]. Here, ST14 is linked to inflammatory breast carcinoma.